Racial Meanings and Scientific Methods: Changing Policies for NIH-Sponsored Publications Reporting Human Variation

Journal of Health Politics, Policy and Law

Volumn 28, Issue 6, 2003, Pages 1033-1087

  Stevens, Jacqueline ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC DIFFERENCE; GENETIC VARIABILITY; GENETICS; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; POPULATION GENETICS; PUBLIC HEALTH; RACE DIFFERENCE; REVIEW; UNITED STATES;

CONTINENTAL POPULATION GROUPS; HUMAN GENOME PROJECT; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PUBLICATIONS; UNITED STATES; VARIATION (GENETICS);

EID: 0347511822     PISSN: 03616878     EISSN: None     Source Type: Journal    
DOI: 10.1215/03616878-28-6-1033     Document Type: Review

References (142)

1. Achen, C., and W. Phillips Shively. 1995. Cross-Level Inferences. Chicago: University of Chicago Press.
2. Altman, D. 2001. What's in a Name'? Today, Not Much. New York Times, 23 August, A18.
3. Appiah, A. 1993. In My Father's House: Africa in the Philosophy of Culture. Oxford: Oxford University Press.
4. Associated Press. 1999. Assailing News Media, Judge Closes Trial Record. New York Times, 16 August, B6.
5. Austin, J. L. 1962. How To Do Things with Words. Oxford: Clarendon.
6. Bailey, L. R., N. Roodi, C. Verrier, C. Yee, W. Dupont, and F. Parl. 1998. Breast Cancer and CYPIa1, GSTM1, and GSTT1 Polymorphisms: Evidence of a Lack of Association in Caucasians and African Americans. Cancer Research 58:65-70.
7. Baram, M. 2001. Making Clinical Trials Safer for Human Subjects. American Journal of Law and Medicine 27:253-282. Available through the AJLM Web site at aslme. org/pub_ajlm.
8. Basile, V. S., V. Özdemir, M. Masellis, M. L. Walker, H. Y. Meltzer, J. A. Liebman, S. G. Potkin, G. Alva, W. Kalow, F. M. Macciardi, and J. C. Kennedy. 2000. A Functional Polymorphism of the Cytochrome P450 1A2 (CYP1A2) Gene: Association with Tardive Dyskinesia in Schizophrenia. Molecular Psychiatry 5:410-417.
9. Bates, R. 1998. Analytic Narratives. Princeton, NJ: Princeton University Press.
10. Borger, Julian. 2000. Researchers Suspected of Hiding Deaths in Gene Tests. Guardian Unlimited, 1 February. Available online at www.guardian.co.uk/genes/article/ 0,2763,191898,00.html.
11. Bullard, R. 1983. Solid Waste Sites and the Black Houston Community. Sociological Inquiry 53:273-288.
12. Cann, R. L., M. Stoneking, and A. C. Wilson. 1987. Mitochondrial DNA and Human Evolution. Nature 325:31-36.
13. Caruso-Nicoletti, M., M. Mancuso, G. Spadero, P. Samperi, C. Consalvo, and G. Schiliro. 1992. Growth and Development in White Patients with Sickle Cell Diseases. American Journal of Pediatric Hematology/Oncology 14(4):285-288.
14. Claus, E., N. Risch, and W. D. Thompson. 1991. Genetic Analysis of Breast Cancer in the Cancer and Steroid Hormone Study. American Journal of Human Genetics 48:232-242.
15. Colditz, G. A., et al. 1993. Family History, Age, and Risk of Breast Cancer: Prospective Data from the Nurses' Health Study. Journal of the American Medical Association 270:805-812.
16. Collins, C., and D. R. Williams. 1999. Segregation and Mortality: The Deadly Effects of Racism? Sociological Forum 14:493-521.
17. Collins, F., L. Brooks, and A. Chakravarti. 1998. A DNA Polymorphism Discovery Resource for Research on Human Genetic Variation. Genome Research 8:1229.
18. Collins, F., M. Guyer, and A. Chakravarti. 1997. Variations on a Theme: Cataloguing Human DNA Variation. Science 278:1580.
19. Collins, F., A. Patrinos, E. Jordon, A. Chakravarti, R. Gesteland, and L. Walters. 1998. New Goals for the Human Genome Project: 1998-2003. Science 282:682-689.
20. Conley, D. 1999. Being Black, Living in the Red. Berkeley: University of California Press.
21. Cooper, R. 1997. Hypertension in the African Diaspora: Genes and the Environment. In Plain Talk about the Human Genome Project, ed. E. Smith and W. Sapp. Tuskegee, AL: Tuskegee University Press.
22. Cooper, R., and C. Rotimi. 1994. Hypertension in Populations of Western African Origin: Is There a Genetic Predisposition? Journal of Hypertension 12:215-227.
23. Cowan, R. S. 1992. Genetic Technology and Reproductive Choice: An Ethics for Autonomy. In The Code of Codes: Scientific and Social Issues in the Human Genome Project, ed. D. Kevles and L. Hood. Cambridge: Harvard University Press.
24. Curtin, P. D. 1992. The Slavery Hypothesis for Hypertension among African Americans: The Historical Evidence. American Journal of Public Health 82:1681-1686.
25. Darwin, C. 1964. On the Origin of Species. Cambridge: Harvard University Press.
26. David, R., and J. Collins Jr. 1997. Differing Birth Weights among Infants of U.S.-born Blacks, African-born Blacks and U.S.-born Whites. New England Journal of Medicine 337:1209-1214.
27. Drosnin, M. 1997. The Bible Code. New York: Simon and Schuster.
28. Durocher, F., D. Shattuck-Eidens, M. McClure, F. Labrie, M. Skolnick, D. Goldgar, and J. Simard. 1996. Comparison of BRCA1 Polymorphisms, Rare Sequence Variants and/or Missense Mutations in Unaffected and Breast/Ovarian Cancer Populations. Human Molecular Genetics 5:835-842.
29. Duster, T. 1990. Backdoor to Eugenics. New York: Routledge.
30. Easton, D. F. 2002. Personal communication (e-mail). 20 February.
31. Easton, D. F., D. T. Bishop, D. Ford, and G. P. Crockford. 1993. Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families. American Journal of Human Genetics 52:678-701.
32. Edlin, G. 1987. Inappropriate Use of Genetic Terminology in Medical Research: A Public Health Issue. Perspectives in Biology and Medicine 31:47-56.
33. Egan, K. M., P. Newcomb, M. Longnecker, A. Trentham-Dietz, J. Baron, D. Trichopoulos, M. Stampfer, and W. Willet. 1996. Jewish Religion and Risk of Breast Cancer. Lancet 347:1645-1646.
34. Feuer, E. J., L. Wun, C. Boring, W. D. Flanders, M. Timmel, and T. Tong. 1993. The Lifetime Risk of Developing Breast Cancer. Journal of the National Cancer Institute 85:892-897.
35. Feuerstein, A. 2002. ImClone Bringing down the Biotech Neighborhood. Available online at www.thestreet.com/tech/adamfeuerstein/10007200.html.
36. Fodor, F., A. Weston, I. Bleiweiss, L. McCurdy, M. Walsh, P. Tartler, S. Brower, and C. Eng. 1998. Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer Patients. American Journal of Human Genetics 63:45-51.
37. Ford, D., D. Easton, D. Bishop, S. Narod, and D. Goldgar. 1994. Risks of Cancer in BRCA-1 Mutation Carriers. Lancet 343:692-695.
38. Ford, D., D. F. Easton, and J. Peto. 1995. Estimates of the Gene Frequency of BRCA1 and Its Contribution to Breast and Ovarian Cancer Incidence. American Journal of Human Genetics 57:1457-1462.
39. Ford, D., D. Easton, M. Stratton, S. Narod, D. Goldgar, P. Devilee, D. T. Bishop, B. Weber, G. Lenoir, J. Chang-Claude, H. Sobol, M. D. Tearing, and J. Struewing. 1998. Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families. American Journal of Human Genetics 62:676-678.
40. Foster, M., D. Bernstein, and T. Carter. 1998. A Model Agreement for Genetic Research in Socially Identifiable Populations. American Journal of Human Genetics 63:696-702.
41. Freeman, H. 2000. The Meaning of Race in Science - Considerations for Cancer Research: Concerns of Special Populations in the National Cancer Program. Cancer 82:219-225.
42. Greely, H. 1992. Health Insurance, Employment Discrimination, and the Genetics Revolution. In The Code of Codes: Scientific and Social Issues in the Human Genome Project, ed. D. Kevles and L. Hood. Cambridge: Harvard University Press.
43. -. 1998. Legal, Ethical, and Social Issues in Human Genome Research. Annual Reviews in Anthropology 27:473-502.
44. Hartge, P., J. Struewing, S. Wacholder, L. Brody, and M. Tucker. 1999. The Prevalence of BRCA1 and BRCA2 Mutations among Ashkenazi Jews. American Journal of Human Genetics 64:963-970.
45. Healy, B. 1997. BRCA Genes-Bookmaking, Fortune-telling, and Medical Care. Editorial. New England Journal of Medicine 336:1448-1449.
46. Hey, J. 2001. Genes, Categories, and Species. New York: Oxford University Press.
47. Holtzman, N., and T. Marteau. 2000. Will Genetics Revolutionize Medicine? New England Journal of Medicine 343(2):141-144.
48. Hopper, J., and M. Jenkins. 1999. Modelling the Probability that Ashkenazi Jewish Women Carry a Founder Mutation in BRCA1 or BRCA2. Comment. American Journal of Human Genetics 65:1771-1776.
49. Horodyski, M. B., R. E. DeMeersman, P. M. Wanderburg, and D. Gallagher. 1995. With Environmental Control, the Effects of Race and Sex on Blood Pressure Regulatory Mechanisms Appear Diminished. Journal of Human Hypertension 9(2):107-111.
50. Hoskins, K. F., J. E. Stopfer, K. A. Calzone, S. D. Merajver, T. R. Rebbeck, J. E. Garber, and B. Weber. 1995. Assessment and Counseling for Women with a History Of Breast Cancer: A Guide for Clinicians. Journal of the American Medical Association 273:573-585.
51. Hunter, T. 1995. Fair Housing Testing - Uncovering Discriminatory Practices. Creighton Law Review 28:1127-1142.
52. Jackson, D. 1960. A Critique of the Literature on the Genetics of Schizophrenia. In The Etiology of Schizophrenia, ed. D. Jackson. New York: Basic.
53. Jackson, F. 1997. Assessing the Human Genome Project: An African American and Bioanthropological Critique. In Plain Talk about the Human Genome Project, ed. E. Smith and W. Sapp. Tuskegee, AL: Tuskegee University Press.
54. Joseph, J. 2001. Don Jackson's "A Critique of the Literature on the Genetics of Schizophrenia - A Reappraisal after 40 Years." Genetic, Social and General Psychology Monographs 127:27-57.
55. -. 2002. Twin Studies in Psychiatry and Psychology: Science or Pseudoscience? Psychiatric Quarterly 73:71-82.
56. Juengst, E. 1998. Identity and Human Diversity: Keeping Biology Straight from Culture. American Journal of Human Genetics 63:673-677.
57. Kapitany, T., K. Meszaros, E. Lenzinger, S. D. Schindler, C. Barnas, K. Fuchs, W. Sieghart, H. N. Aschauer, and S. Kasper. 1998. Genetic Polymorphisms for Drug Metabolism (CYPD6) and Tardive Dyskinesia in Schizophrenia. Schizophrenia Research 32:101-106.
58. Kato, C., et al. 2002. Molecular Genetic Studies of Schizophrenia: Challenges and Insights. Review Article. Neuroscience Research 43:295-304.
59. Kaufman, J., and S. Hall. 2003. The Slavery Hypertension Hypothesis: Dissemination and Appeal of a Modern Race Theory. Epidemiology and Society 14:111-118.
60. Keller, E. F. 1995. Refiguring Life: Metaphors of Twentieth-Century Biology. New York: Columbia University Press.
61. Khoury, M. J., and R. Thornburg. 2001. Will Genetics Revolutionize Medicine? 2 January. Available online at geneletter.com/01-02-01/features/medicine.html.
62. Khoury, M. J., and Q. Yang. 1998. The Future of Genetic Studies of Complex Human Diseases: An Epidemiologic Perspective. Epidemiology 9:350-354. Available online at www.cdc.gov/genetics/info/reports/research/future2.htm.
63. King, G., R. Keohane, and S. Verba. 1994. Designing Social Inquiry: Scientific Inference in Qualitative Research. Princeton, NJ: Princeton University Press.
64. Kneese, A., and W. Schulze. 1977. Environment, Health, and Economics - The Case of Cancer. American Economic Review 67:326-332.
65. Knoppers, B. M., M. Hirtle, and S. Lormeau. 1996. Ethical Issues in International Collaborative Research on the Human Genome: HGP and the HGDP. Genomics 34:272-282.
66. Krieger, N. 1990. Racial and Gender Discrimination: Risk Factors for High Blood Pressure? Social Science Medicine 30:1273-1281.
67. Krieger, N., and S. Sidney. 1996. Racial Discrimination and Blood Pressure: The CARDIA Study of Young Black and White Adults. American Journal of Public Health 86:1370-1378.
68. Lander, E. 1992. DNA Fingerprinting: Science, Law, and the Ultimate Identifier. In The Code of Codes: Scientific and Social Issues in the Human Genome Project, ed. D. Kevles and L. Hood. Cambridge: Harvard University Press.
69. LaVeist, T. 1993. Segregation, Poverty and Empowerment: Health Consequences for African Americans. Milbank Quarterly 71:41-64.
70. Lee, S. S-J., J. Mountain, and B. A. Koenig. 2001. The Meanings of Race in the New Genomics: Implications for Health Disparities Research. Yale Journal of Health Policy, Law, and Ethics 1:33-75.
71. Locke, J. 1960 [1689]. Two Treatises of Government. Cambridge: Cambridge University Press.
72. Luz, C. 1999. Socioeconomic Factors and Asthma Hospitalization Rates in New York City. Journal of Asthma 36:343-350.
73. Madsen, D. 1985. A Biochemical Property Relating to Power Seeking in Humans. American Political Science Review 79:448-457.
74. -. 1986. Power Seekers Are Different: Further Biochemical Evidence (research note). American Political Science Review 80:261-270.
75. Malone, K., J. Daling, J. Thompson, C. O'Brien, L. Francisco, and E. Ostrander. 1998. BRCA1 Mutations and Breast Cancer in the General Population: Analyses in Women before Age 35 Years and in Women before Age 45 Years with First-Degree Family History. Journal of the American Medical Association 279:922-929.
76. Mao, X. 1998. Chinese Ethicists' Views of Ethical Issues in Genetic Testing and Screening: Evidence of Eugenics in China. American Journal of Human Genetics 63:688-695..
77. Marshall, E. 1997. Playing "Chicken" over Gene Markers. Science 278:2096.
78. -. 1998. DNA Studies Challenge the Meaning of Race. Science 282:654.
79. -. 1999. A High Stakes Gamble on Genome Sequencing. Science 284:1906.
80. Massey, D. S., and N. A. Denton. 1993. American Apartheid: Segregation and the Making of the Underclass. Cambridge: Harvard University Press.
81. Mayr, E. 1942. Systematics and the Origin of Species. New York: Columbia University Press.
82. McCreddie, M. R. E., et al. 1998. Breast Cancer in Australian Women under the Age of 40. Cancer Cause Control 9:189-198.
83. Micklos, D., and E. Carlson. 2000. Engineering American Society: The Lesson of Eugenics. Nature Reviews 1:153-158.
84. Molotsky, I. 1999. New Dawn for Flag That Was Still There. New York Times, 16 May.
85. Moshlehi, R., W. Chu, B. Karlan, D. Fishman, H. Risch, A. Fields, D. Smotkin, Y. Ben-David, J. Rosenblatt, D. Russo, P. Schwartz, N. Tung, E. Warner, B. Rosen, J. Friedman, J. Brunet, and S. Narod. 2000. BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer. American Journal of Human Genetics 66:1259-1272.
86. Murray, R. F. Jr. 1991. Skin Color and Hypertension: Genetics or Environment? Journal of the American Medical Association 265:639-640.
87. Murray, T. 1997. Genetic Discrimination in Health Insurance and Why It Is Wrong. In Plain Talk about the Human Genome Project, ed. E. Smith and W. Sapp. Tuskegee, AL: Tuskegee University Press.
88. Nathanson, C. 1999. Social Movements as Catalysts for Policy Change. Journal of Health, Policy and Law 24:421-488.
89. Newman, B. 2002. Personal communication (e-mail), 21 January.
90. Newman, B., M. Austin, M. Lee, and M. King. 1988. Inheritance of Human Breast Cancer: Evidence for Autosomal Dominant Transmissions in High-Risk Families. Proceedings of the National Academy of Sciences 85:3044-3048.
91. Newman, B., H. Mu, L. Butler, R. Milikan, P. Moorman, and M. King. 1998. Frequency of Breast Cancer Attributable to BRCA1 in a Population-Based Series of American Women. Journal of the American Medical Association 279:915.
92. Noah, B. 1998. Racial Disparities in the Delivery of Health Care. San Diego Law Review 35:135-177.
93. Noronha, P. A. 1979. Sickle Cell Anemia in Two White American Children: Essential Laboratory Criteria for Diagnosis. Pediatrics 63:242-246.
94. Oddoux, C., J. P. Struewing, C. M. Clayton, S. Neuhausen, L. C. Brody, M. Kaback, B. Haas, L. Norton, P. Borgen, S. Jhanwar, D. Goldgar, H. Ostrer, and K. Offit. 1996. The Carrier Frequency of the BRCA2 6174de1T Mutation among Ashkenazi Jewish Individuals Is Approximately 1%. Nature Genetics 14:188-190.
95. Oliver, M., and T. Shapiro. 1995. Black Wealth/White Wealth: A New Perspective on Racial Inequality. New York: Routledge.
96. Pennisi, E. 1997. NRC OKs Long-Delayed Survey of Human Genome Diversity. Science 278:568.
97. Peto, J., N. Collins, S. Barfoot, S. Seal, W. Warren, N. Rahman, D. F. Easton, C. Evans, J. Deacon, and M. R. Stratton. 1999. Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Early-onset Breast Cancer. Journal of the National Cancer Institute 91:943-949.
98. Phillips, K. A., D. L. Veenstra, E. Oren, J. K. Lee, and W. Sadee. 2001. Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions (review article). Journal of the American Medical Association 286:2270-2279.
99. Reynolds, S. 1984. Kingdoms and Communities in Western Europe: 900-1300. Oxford: Clarendon.
100. Risch, N., E. Burchard, E. Ziv, and H. Tang. 2002. Categorization of Humans in Biomedical Research: Genes, Race and Disease." Genome Biology 3(7):2007.1-2007.12.
101. Roche, P., L. Glantz, and G. Annas. 1997. The Genetic Privacy Act: A Proposal for National Legislation. In Plain Talk about the Human Genome Project, ed. E. Smith and W. Sapp. Tuskegee, AL: Tuskegee University Press.
102. Rosenthal, T., E. Grossman, A. Knecht, and U. Goldbourt. 1990. Levels and Correlates of Blood Pressure in Recent and Earlier Ethiopian Immigrants to Israel. Journal of Human Hypertension 4:425-430.
103. Sadee, W. 1999. Pharmacogenomics (interview by Clare Thompson). British Journal of Medicine 319:1-4.
104. Sarkar, S. 1998. Genetics and Reductionism. Cambridge: Cambridge University Press.
105. Slattery, M. L., and R. Kerber. 1993. A Comprehensive Evaluation of Family History and Breast Cancer Risk: The Utah Population Database. Journal of the American Medical Association 270:1563-1568.
106. Smith, E., and W. Sapp, eds. 1997. Plain Talk about the Human Genome Project. Tuskegee, AL: Tuskegee University Press.
107. Stevens, J. 1999. Reproducing the State. Princeton, NJ: Princeton University Press.
108. -. 2002. Symbolic Matter: DNA and Other Linguistic Stuff. Social Text 20:106-140.
109. -. Forthcoming. Methods of Adoption. In The View from Home: Philosophical and Feminist Issues in Adoption, ed. S. Haslanger and C. Witt.
110. Stoneking, M. 1999. Comments at Human Evolution Meeting, Cold Spring Harbor Laboratory, Cold Spring, NY, 21-25 April.
111. Strachan, T., and A. P. Read. 1999. Genetic Mapping of Mendelian Characteristics. In Human Molecular Genetics, ed. T. Strachan and A. P. Read. Vol. 2. Oxford: BIOS Scientific.
112. Struewing, J., D. Abeliovich, T. Peretz, N. Avishai, M. M. Kaback, F. S. Collins, and L. C. Brody. 1995. The Carrier Frequency of the BRCA1 185de1AG Mutation Is Approximately 1 Percent in Ashkenazi Jewish Individuals. Nature Genetics 11:198-200.
113. Struewing, J., P. Hartge, S. Wacholder, S. M. Baker, M. Berlin, M. McAdams, and M. M. Timmerman. 1997. The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine 336:1401-1408.
114. Thomas, C., A. Ehrhardt, and M. Kay. 2003. Problems and Progress with the Use of Viral Vectors for Gene Therapy. Nature Review Genetics 415:346-58.
115. University of Pittsburgh Medical Center. 1999. University of Pittsburgh Medical Center Performs First in Vivo Gene Therapy for Hemophilia A. News release available online at www.upmc.edu/NewsBureau/science/hemophilia.htm.
116. U.S. Census Bureau. 1999. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. 1 April. Available online through the Census Bureau Web site at www.census.gov/population/www/socdemo/race/Ombdir15.html.
117. -. 2000. "SIPPS Data Source Description" accompanying Table POP5.B: Percentage of Children under Age 18 Living in Various Family Arrangements. Available online at www.childstats.gov/ac2000/poptxt.asp: www.childstats.gov/ac2000/ surveys.asp#sipp; and www.childstats.gov/ac2000/poptxt.asp.
118. U.S. Centers for Disease Control (CDC). 1997. National Health Interview Survey. Washington, DC: U.S. Government Printing Office.
119. U.S. Department of Energy (DOE). 1998. Human Genome News, January. Published online at www.orn1.gov/TechResources/Human_Genome/publicat/hgn/v9n1/ 20ednote.html.
120. -. 2000. Long-term Stewardship Study. Available online at www.em.doe.gov/ ftplink/1ts/1tsdraft.pdf.
121. U.S. Food and Drug Administration (FDA). 2001. FDA Approves Gleevec for Leukemia Treatment. FDA news release available online at www.fda.gov/bbs/ topics/NEWS/2001/NEW00759.html.
122. U.S. National Academy of Sciences (NAS). 1999. Toward Environmental Justice: Research, Education, and Health Policy Needs. Available through the National Academies Press Web site at www.nap.edu/openbook/0309064074/html/13.html
123. -. 2000. Clearing the Air: Asthma and Indoor Air Exposures. Available through the National Academies Press Web site at www.nap.edu/openbook/0309064961/ html/19.html.
124. U.S. National Cancer Institute (NCI). 2000. Questions and Answers for Estimating Cancer Risk in Ashkenazi Jews: Cancer Facts. CancerNet Fact Sheet. Available online at cancernet.nci.nih.gov.
125. U.S. National Heart, Lung, and Blood Institute (NHLBI). 1997. Asthma Genes Linked to Regions Unique to Different Racial and Ethnic Groups, NHLBI Study Shows. NIH press release available online at www.nih.gov/news/pr/mar97.
126. U.S. National Human Genomics Research Institute (NHGRI). 1996. Prostate Cancer Gene Location Found on Chromosome 1. Available online at www.nhgri.nih.gov/ DIR/LCG/PROSTATE/pros_media_tel.html.
127. -. 1999. Studies of the Ethical, Legal, and Social Implications of Research into Human Genetic Variation. 29 April. Available online at www.nhgri.nih.gov/ Grant_info/Funding/RFA-HG-99-002.html.
128. U.S. National Institute for Allergies and Infectious Diseases (NIAID). 2000. International Team Accelerates Investigation of Immune-Related Genes. NIAID press release available (as of 16 May 2003) online at www.niaid.nih.gov/newsroom/ releases/ihwg.htm.
129. U.S. National Institute of Arthritis and Muskuloskeletal and Skin Disease (NIAMS). 1998. An NIH-Funded Native American Study Finds Gene Site Associated with Scleroderma. NIH press release available online at www.niams.nih.gov/ne/press/ 1998/10.29.
130. U.S. National Institutes of Health. 1997a. NIH Leads International Group That Identifies Gene for Familial Mediterranean Fever: Mutations Date Back to Biblical Times. Available online at www.nih.gov/news/pr/aug97/niams-21.htm.
131. -. 1997b. Researchers Locate Lupus Gene on Chromosome 1. Available online at www.nih.gov/news/pr/feb97/niams-19.htm.
132. U.S. National Research Council (NRC) Committee on Human Genome Diversity. 1997. Evaluating Human Genetic Diversity. Washington, DC: National Academy Press.
133. Wade, N. 2000. Whose DNA Is It? In a Way, Nobody's. New York Times, 27 June, F2.
134. -. 2002. Scientist Reveals Secret of Genome: It's His. New York Times, 27 April, A1.
135. Watson, J. D. 1987. Molecular Biology of the Gene. 4th ed. 2 vols. Menlo Park, CA: Benjamin/Cummings.
136. Whittemore, A., G. Gong, and J. Itnyre. 1996. Prevalence and Contributions of BRCA1 Mutations in Breast Cancer and Ovarian Cancer: Results from Three U.S. Population-Based Case-Control Studies of Ovarian Cancer. American Journal of Human Genetics 60:496-504.
137. Williams, D. R., Y. Yu, J. S. Jackson, and N. B. Anderson, 1997. Racial Differences in Physical and Mental Health. Journal of Health Psychology 2:335-351.
138. Wilson, J., M. Weale, A. Smith, F. Gratix, B. Fletcher, M. G. Thomas, N. Bradman, and D. B. Goldstein. 2001. Population Genetic Structure of Variable Drug Response. Nature Genetics 29:265-269.
139. Wilson, T. W., and C. E. Grim. 1991. Biohistory of Slavery and Blood Pressure Differences in Blacks Today: A Hypothesis. Hypertension 17(supp. 1): 122-128.
140. Wittgenstein, L. 1968. Philosophical Investigations. 3d ed. New York: Macmillan.
141. Xu, X., and U. Arnason. 1996. The Mitochondrial DNA Molecule of Sumatran and a Molecular Proposal for Two (Bornean and Sumatran) Species of Orangutan. Journal of Molecular Evolution 43:431-437.
142. Zilinskas, R. 1997. Global Perspectives on the Human Genome Project. In Plain Talk about the Human Genome Project, ed. E. Smith and W. Sapp. Tuskegee, AL: Tuskegee University Press.